Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 16.96% | -0.97% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.96% | -0.97% | |||
| Cost of Revenue | 1.60% | 1.83% | |||
| Gross Profit | 31.79% | -3.53% | |||
| SG&A Expenses | 15.99% | -8.98% | |||
| Depreciation & Amortization | -1.54% | -2.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.56% | -2.80% | |||
| Operating Income | 764.29% | 380.00% | |||
| Income Before Tax | 217.65% | -109.12% | |||
| Income Tax Expenses | 83.72% | -122.05% | |||
| Earnings from Continuing Operations | 937.50% | -102.20% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 937.50% | -102.20% | |||
| EBIT | 764.29% | 380.00% | |||
| EBITDA | 104.35% | -16.36% | |||
| EPS Basic | 935.19% | -102.20% | |||
| Normalized Basic EPS | 256.65% | 31.27% | |||
| EPS Diluted | 763.27% | -102.68% | |||
| Normalized Diluted EPS | 255.40% | 30.85% | |||
| Average Basic Shares Outstanding | 0.14% | 0.02% | |||
| Average Diluted Shares Outstanding | 0.95% | -0.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||